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Abstract
Mass spectrometry (MS) promises to be an invaluable tool for functional genomics, by supporting
low-cost, high-throughput experiments. However, large-scale MS faces the potential problem of mass de-
generacy | indistinguishable masses for multiple biopolymer fragments (e.g. from a limited proteolytic
digest). This paper studies the tasks of planning and interpreting MS experiments that use selective
isotopic labeling, thereby substantially reducing potential mass degeneracy. Our algorithms support an
experimental-computational protocol called Structure-Activity Relation by Mass Spectrometry (SAR by
MS), for elucidating the function of protein-DNA and protein-protein complexes. SAR by MS enzy-
matically cleaves a crosslinked complex and analyzes the resulting mass spectrum for mass peaks of
hypothesized fragments. Depending on binding mode, some cleavage sites will be shielded; the absence
of anticipated peaks implicates corresponding fragments as either part of the interaction region or inac-
cessible due to conformational change upon binding. Thus dierent mass spectra provide evidence for
dierent structure-activity relations. We address combinatorial and algorithmic questions in the areas
of data analysis (constraining binding mode based on mass signature) and experiment planning (deter-
mining an isotopic labeling strategy to reduce mass degeneracy and aid data analysis). We explore the
computational complexity of these problems, obtaining upper and lower bounds. We report experimental
results from implementations of our algorithms.
Keywords: Mass spectrometry, functional genomics, experiment planning, data analysis, methods for
biopolymer structure, protein-protein and DNA-protein complexes.
1 Introduction
We wish to develop high-throughput algorithms for the structural and functional determination of the pro-
teome. We believe that algorithms can be designed that require data measurements of only a few key
biophysical parameters, and these will be obtained from fast, minimal, and cheap experiments. We envision
that, after input to computer modeling and analysis algorithms, structure and function of biopolymers can
be assayed at a fraction of the time and cost of current methods. Our long-range goal is the structural and
functional understanding of biopolymer interactions in systems of signicant biochemical as well as phar-
macological interest. An example of such computational approaches is the Jigsaw program of Donald and
coworkers [7] for high-throughput protein structure determination using NMR.
In this paper, we introduce new computational techniques for experiment planning and data analysis in
a methodology called SAR by MS (Structure-Activity Relation by Mass Spectrometry) for use in functional
genomics. SAR by MS is a combined experimental-computational protocol in which the function and binding

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Figure 1: Mass tags can eliminate potential degeneracies in fragment hypotheses.
mode of DNA-protein and protein-protein complexes can be assayed quickly.
1
It uses a combination of
accurate mass measurement of degradation products of the analyte complexes, and mathematical algorithms
for data analysis and experiment planning, to maximize the information obtained by the mass measurements.
In SAR by MS, a complex is rst modeled computationally to obtain a set of binding-mode and binding-
region hypotheses. Next, the complex is crosslinked and then cleaved at predictable sites (using proteases
and/or endonucleases), obtaining a series of fragments suitable for MS. Depending on the binding mode,
some cleavage sites will be shielded by the crosslinking. Residues exposed in the isolated proteins that
become buried upon complex formation are considered to be located either within the interaction regions or
inaccessible due to conformational change upon binding. Thus, depending on the function, we will obtain
a dierent mass spectrum. Analysis of the mass spectrum (and perhaps comparison to the spectra of the
uncomplexed constituents) permits determination of binding mode and region.
A key issue in SAR by MS is the potential for mass degeneracy: when two potential fragments have
approximately the same mass (within the resolution of the spectrum), the existence of one or the other cannot
be uniquely inferred from a mass peak. To overcome this problem, we propose the use of computational
experiment planning to determine how to selectively manipulate masses (isotopically label) with
13
C and
15
N enrichment in order to minimize or avoid potential mass degeneracy.
2
Selective isotopic labeling allows,
for example, all Leu and Ala residues in a protein to be labeled using either auxotrophic bacterial strains
or cell-free synthesis. Mass tags | the mass dierences between unlabeled and labeled proteins | can
eliminate mass degeneracy by ensuring that potential fragments have distinguishable masses. For example,
in Fig. 1, when X and Y are crosslinked, their combined mass is nearly identical to that of Z. By labelling,
we ensure that the mass of X+Y is dierent from Z, thereby allowing SAR by MS to distinguish among the
set of binding hypotheses. DNA can also be isotopically labeled, as is illustrated in Fig. 2. Here, we have
1
Biological function is a complex phenomenon. In this paper, we use the term \function" in the very limited sense of
structure-activity relation (binding mode and region).
2
Labeling with
2
H and
18
O is also experimentally possible; algorithmic extensions are straightforward.
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Figure 2: MALDI-TOF mass spectra of an 18 bp DNA oligonucleotide d(GACATTTGCGGTTAGGTC):
(top)
13
C-,
15
N-labeled 18-mer; (bottom)
12
C,
14
N-labeled 18-mer. The dierence between the two spectra is
called the mass tag.
synthesized and recorded mass spectra for an isotopically-labeled 18-mer [20, 13]. The
13
C-,
15
N-labeled
oligonucleotide (top) has a mass tag when compared with its unlabeled counterpart (bottom).
Our work addresses the issue of explicitly planning experiments to minimize mass degeneracy, via the cal-
culation and implementation of specic constraints. We incorporate selective stable isotopic labeling within
the analytes. The constraints therefore reect the partial amino acid content (or nucleotide composition) and
the mass-to-charge ratio (m=z) of the analytes. Note that there exist other types of constraints that could be
employed in conjunction with stable isotopic labeling. For example: (i) use of a tandem mass spectrometer
to generate collision induced dissociation spectra of the (peptide) analytes [28, 16, 21]; (ii) use of dierent
enzymes to generate the fragments prior to mass analysis [8, 19]; (iii) use of group-specic crosslinkers that
would indicate the presence of a (constraining) amino acid in the peptide sequence [25] (see Ex. 2); (iv) use
of a crosslinker that introduces a mass increment that reduces or eliminates mass degeneracy. None of these
experimental techniques have been addressed in terms of computational experiment planning, nor as an
optimization problem, nor with the goal of automation for eliminating mass degeneracy. It is important to
realize that these other methods are informationally orthogonal to stable isotopic labeling. That is, selective
labeling will add information content to any of the proposed methods above, by providing very ne-grained
control of peptide and oligo masses. Similarly, planning selective labeling can be useful in MS protocols other
than SAR by MS. In this paper, we demonstrate our technique only for SAR by MALDI-TOF MS (Matrix-
Assisted Laser Desorption/Ionization Time-Of-Flight Mass Spectrometry); extensions to the methods above
are planned in the future.
Experimental techniques relevant to SAR by MS have been studied by a number of researchers. For
example, Pucci and coworkers [25] investigated a combined strategy integrating limited proteolysis and
crosslinking experiments with mass spectrometry. It is hypothesized that the interface regions of two inter-
3
acting proteins are accessible to the solvent in the isolated molecules, but become protected following the
formation of the complex [8, 19]. Therefore, the interface regions can be inferred from dierential peptide
maps obtained from limited proteolysis experiments on both the isolated proteins and the complex. Photo-
and chemical crosslinking reactions lead to the identication of spatially close amino acids residues in the
complex. Mass spectrometry can be employed both to dene the cleavage sites and to identify the covalently
linked fragments.
In this paper, we rst formalize the problem of SAR by MS and mass degeneracy. We then study
experiment planning strategies, both for optimizing a single experiment and for combining information across
multiple experiments. We prove that, under some fairly natural conditions, an abstraction of the optimal
experiment planning problem is NP-complete. We present results from the application of a randomized
experiment planning algorithm to the proteins of the complex Ubiquitin Carrier Protein ubc9/Ubiquitin-
Like Protein ubl1 (SMT3C). We next address the data analysis problem, introducing an output-sensitive
polynomial-time algorithm for data analysis using the technique of spectral dierencing. Finally, we present
a novel probabilistic framework bridging experiment planning and data analysis, estimating actual mass
degeneracy from an analysis of the statistics of hypothesis degeneracy.
2 Problem Denition
2.1 Experimental Setup
We now briey review some aspects of the experiment design.
2.1.1 Resolution and Mass Range
MALDI and ESI (Electrospray Ionization) produce gas-phase ions of biomolecules for their analysis by MS.
ESI produces a distribution of ions in various charge states, whereas MALDI yields predominantly singly-
charged ions. Therefore, ESI spectra are correspondingly more complex. Smith and coworkers [24] have
shown how to reduce the charge state of ESI ions, to obtain greatly simplied spectra in which fragments
are manifested as single mass peaks (similar to MALDI). The decreased spectral complexity aorded by
charge reduction facilitates the analysis of mixtures by ESI MS. While the mass limit for MALDI is about
a megadalton, charge-reduction TOF ESI has a mass limit of about 22 kDa. ESI appears to respect weak
covalent interactions (such as the hydrogen bonds) [22], whereas complexes for MALDI must be covalently
crosslinked.
MALDI MS is orders of magnitude better than traditional gel techniques in terms of mass resolution,
cycle time, and sample sizes. For example, its mass resolution is one dalton in 10
4
-10
5
(or 10
6
with FT-
ICR [26]). Indeed, MALDI FT-ICR allows distinguishing reduced vs. oxidized states of Cys residues in large
proteins, although to obtain this resolution, depletion of the naturally abundant
13
C and
15
N isotopes is often
necessary [23]. These quantitative dierences make SAR by MS an attractive method for high-throughput
functional genomics [24, 22].
2.1.2 Crosslinking
Crosslinking (the covalent linking of a multimer) is most commonly used for DNA-protein complexes. For
protein-protein complexes, a residue can be mutated to a photoreactive amino acid such as p-benzoyl L-
phenylalanine (BPA) [11]. After exposure to UV light, the complex is crosslinked. Proteins interact with
their substrates on the basis of their 3D fold. If protein complexes are digested, generally the 3D structure of
the interacting segments gets distorted or destroyed and the interactions are disrupted. Without crosslinking
it is unlikely that the interactions would be preserved in the fragments to be observed by MS. For this reason,
we crosslink our complexes, and we restrict our attention in this paper to MALDI MS. It is worth noting
that selective isotopic labeling can add information content to ESI MS, in which the experiment planning
algorithm would be similar. This is an interesting direction for future work.
4
2.1.3 Stable Isotopic Labeling
Uniform and selective labeling of proteins is a standard molecular biology protocol (e.g., for heteronuclear
protein NMR). Until recently, the methodology for the uniform and selective labeling of DNA needed to
perform these MS experiments was not available. However, recent advances in the enzymatic synthesis of
13
C and
15
N-labeled DNA in milligram quantities have the potential to revolutionize the NMR and MS
analysis of nucleic acids (see Fig. 2 and [13]). The feasibility of selective labeling for stable isotope assisted
mass spectrometry has been experimentally demonstrated by [12, 14]. The experiments were planned and
interpreted manually; this papers gives algorithms for automating both processes.
2.2 Computational Model
This section introduces a mathematical abstraction capturing the essence of the biological problem. In this
investigation of SAR by MS, we focus on the problem of determining the binding mode of a protein-protein
complex using
13
C- and
15
N-selective labeling followed by MS. We defer the problem of planning cleavage
strategies, and assume the use of a xed protease (e.g. trypsin, which cleaves the peptide bond following
Lys and Arg residues). We also defer generation of a priori binding mode hypotheses. This type of data is
available from several sources, including docking studies such as [10, 27], together with homology searching,
DNA footprinting, and mutational analysis. When available, these hypotheses provide priors that restrict
the set of fragment interpretations.
2.2.1 Fragments
A protein or protein-protein complex is digested by a protease, yielding a set of fragments. There may be
many more potential fragments F than observed fragments F

| exposed cleavage sites in the isolated pro-
teins might be inaccessible in the complex, due to incomplete digestion, conformational change upon binding,
or shielding within an interaction region. The regions of the primary sequence between adjacent (accessible)
cleavage sites are called segments. Protein 1-fragments are formed of sequential unions of segments.
Example 1 If a peptide of 20 residues has cleavage sites 5 and 10, then the segments are (1,5), (6,10), and
(11,20). The 1-fragments are these 3 segments, plus (1,10), (1,20), and (6,20).
When two interacting proteins are crosslinked and cleaved, a 2-fragment may be formed by the binding of
one 1-fragment from each protein. The mass spectrum will then exhibit a peak at the mass of the 2-fragment.
2-fragment masses are not simply the sum of 1-fragment masses, since crosslinking can increase or decrease
the mass of both crosslinked and exposed residues. However, since the change is predictable, it can easily
be incorporated into our framework and modeled as a mass shift. We take a peak at a 2-fragment mass as
evidence that the two constituent 1-fragments are implicated in the interface region of the protein-protein
complex. In particular, such a 2-fragment is formed by crosslinking the interface regions, followed by cleavage
on each protein strand.
Example 2 Consider the interaction of 1-fragments fg
1
; g
2
; g
1
[ g
2
g of one protein with 1-fragment h of
another. One binding hypothesis is that h binds g
1
or g
2
and the cleavage site g
1
=g
2
is shielded (either by h or
some other fragment). This hypothesis is encoded as the single 2-fragment g
1
[ g
2
[ h. Let m(g
1
) denote the
mass of g
1
, etc. If the hypothesis is false, the mass spectrum should contain three peaks fm(g
1
);m(g
2
);m(h)g,
else it should contain one peak m(g
1
)+m(g
2
)+m(h)+m(g
1
; g
2
; h), where m(g
1
; g
2
; h) denotes the change
in mass due to crosslinking.
Example 3 Another binding hypothesis for Ex. 2 is that the complex shields the proteolytic site g
1
/g
2
, but
without h binding g
1
or g
2
. This hypothesis is supported by a spectrum containing two peaks fm(g
1
) +m(g
2
);m(h)g.
However, this spectrum could also support other hypotheses (e.g. g
1
and g
2
are in the core, shielded from pro-
teolytic digestion). Thus we must compare the spectrum for the cleaved g-protein in isolation. If the isolated
spectrum contains fm(g
1
);m(g
2
)g then the g
1
/g
2
cleavage site is exposed in isolation and protected [29, 15]
in the complex. Therefore the residues at the g
1
/g
2
site are considered to be located either within the interac-
tion regions in the complex, or inaccessible due to conformational change upon binding. On the other hand,
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if it contains a peak m(g
1
) +m(g
2
), there is no evidence that the g
1
/g
2
site is implicated in the interaction
region.
Our algorithm is based on the assumption that the sequence segments responsible for the interactions
are (a) contiguous and (b) preserved if the proteins are digested. (a) is assumed strictly for combinatorial
reasons. If (a) fails, then our method still works, but with a penalty in combinatorial complexity. Refer to
the experimental setup subsection on the use of crosslinking for a discussion of (b).
2.2.2 Mass Degeneracy
Mass degeneracy results when the masses of two fragments are indistinguishable within the resolution of a
particular spectrum. Our goal is to use selective labeling to force the fragment masses to be distinct. A
selective labeling scheme uses dierent isotopes in specic amino acids (e.g. Arg with
15
N instead of
14
N) to
aect the resulting mass spectrum.
Given (any) two fragments k; l 2 F , we wish to plan a labeling such that their masses are distinct
whenever k 6= l. That is
X
i2R
n
ki
(m
i
+ x
i
) 6=
X
i2R
n
li
(m
i
+ x
i
); (1)
where R is the set of residues fAla, Arg, Asn, Asp,: : :g plus a \pseudo-residue" term for the appropriate
crosslinker (see Ex. 2), m
i
is the unlabeled monoisotopic integer mass of residue type i, x
i
is the additional
mass of residue i after labeling, and n
ki
(resp. n
li
) is the number of residues of type i in fragment k (resp. l).
Note that
x
i
2 f0; c^
i
; n^
i
; c^
i
+ n^
i
g; (2)
where c^
i
and n^
i
are the additional mass after labeling residue type i with
13
C and
15
N, respectively. Thus,
for example, for i = 2 (Arginine), m
2
= 156, c^
2
= 6, and n^
2
= 4. Now, let
N
kl
= (n
k1
  n
l1
; n
k2
  n
l2
; n
k3
  n
l3
; : : :); (3)
C
kl
= N
kl
 (m
1
;m
2
; : : :); (4)
X = (x
1
; x
2
; : : :): (5)
Then Eq. (1) can be written as the constraint
f
kl
(X) 6= 0; where f
kl
(X) = N
kl
X + C
kl
: (6)
We have a constraint of the form Eq. (6) for every pair of distinct fragments k and l. Whenever a constraint
f
kl
is violated, we obtain mass degeneracy (two fragments with the same mass). This constraint can be
expressed as a disjunction of inequality relations (that is, < or >). Inequalities can also enforce peak
separation in the spectrum. For example, to ensure a peak separation of at least Æ, Eq. (6) becomes the
disjunction
3
f
kl
(X) > Æ or f
kl
(X) <  Æ:
2.2.3 Basic Combinatorics
Let p = jFj be the number of potential fragments after crosslinking and trypsin cleavage, and n = jRj be the
size of the set R, that is, the number of residue types. Then the number of constraints m of type Eq. (6) is
O(p
2
). Although in theory n is bounded by a constant of about 20, exhaustive search is not possible, since
there are approximately 4
n
dierent labeling schemes. We begin by treating n and m as parameters that
measure the input complexity of the problem.
To bound the number of fragments, p, we consider a 2-protein complex, in which each protein has s
cleavage sites. Since any cleavage point can be shielded, a protein with s cleavage sites can have O(s
2
)
1-fragments. Since we can choose any 1-fragment from each protein, there are p = O(s
4
) 2-fragments.
Now, in any MS experiment, we will only see peaks from some of these fragments. These are because the
3
In practice, mass degeneracy is given in parts per thousand, not as constant. We can encode this by making Æ dependent
on k and l, and rewriting this equation as f
kl
(X) > Æ
kl
or f
kl
(X) <  Æ
kl
.
6
fragments may represent competing (mutually exclusive) hypotheses about binding modes. However, in
terms of experiment planning, we must be able to distinguish between any pair of hypotheses. Hence, we
have O(p
2
) = O(s
8
) constraints.
It is clear that not all 1-fragment/1-fragment interactions are possible. Some may be excluded based
on 1-fragment length. For example, it may be impossible to shield two cleavage sites that are t-apart with
a single u-mer if u  t. Such reasoning requires careful modeling: for example, the longer strand may be
heavily kinked. Computational methods can be employed to form hypotheses about binding modes. These
should greatly help the combinatorics, since an experiment would only need to distinguish the fragments
identied by hypothesis, and could allow degeneracy in unrelated fragments. In this model, predictions of
docking and binding would be made on the computer, and labeling+MS would be performed as a way of
screening these hypotheses to test which are correct.
3 Experiment Planning
3.1 Single-Experiment Planning
The goal of single-experiment planning is to nd a labeling X that minimizes the amount of mass degeneracy.
To do this, we attempt to minimize the number of constraint violations of the form f
kl
(X) = 0 (refer to
Eq. (6)). An exact solution to this optimization problem would nd the best labeling|that is, the labeling
that minimizes the number of constraint violations, and hence the \amount" of mass degeneracy. An
approximate solution would come \close"|for example, within an (1 + ") factor of the minimum, for some
small ".
The problem of planning a single-experiment labeling plan can be viewed as an optimization problem.
We call this problem omsep forOptimal Mass Spectrometry Experiment Planning. Experimentally,
omsep appears diÆcult to solve eÆciently. omsep is an instance of the NP-complete problem Minimum
Unsatisfying Linear Subsystem (muls) [3, 17, 5, 4, 6, 18, 1]. We show that a variant of omsep is
NP-complete (the proof is in the appendix):
Lemma 1 omsep, even restricted to using only
13
C selective labeling, is NP-complete.
3.2 Multiple-Experiment Planning
The single-experiment planning problem omsep is intractable. Even if we could solve it, the resulting
labelling might have too much mass degeneracy. Therefore, we pursue a dierent approach, allowing experi-
ment plans to use several dierent labelings. First, we explore a necessary condition for experiment planning.
Next, we present a stronger, suÆcient condition and then discuss how a practical, necessary and suÆcient
condition may be obtained.
3.2.1 A Necessary Condition
In the Necessary Condition approach, we label the proteins in several dierent ways, to produce several
samples. MALDI MS is performed on each sample. We do not require that each pair of fragments have
distinct masses in every labeling-MS experiment. However, we do require that for every pair of fragments,
there exists some labeling in which their masses are distinct.
4
Let L be a set of labelings. L may be represented by a set L = fX
1
; X
2
; : : :g where each X
i
is a point
of the form X in Eq. (5). For a pair of fragments k and l, and a labeling X 2 L, we can ask whether their
masses are distinct under labeling X . That is:
f
kl
(X) 6= 0?
(The constraint f
kl
is given in Eq. (6).) Hence, our necessary condition is:
4
Note that fragments whose primary sequences are permutations of one another cannot be distinguished by labeling+MS.
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Feasibility Condition: Find a set of labelings L = fX
1
; X
2
; : : :g such that for every pair of fragments k
and l, either k = l or there exists some labeling X
kl
2 L, such that f
kl
(X
kl
) 6= 0. We call L a Feasible Set
of Labelings.
The Feasibility Condition can be converted into an optimization problem|for example, minimizing the
number of experiments or the number of dierent amino acids labeled in each experiment. Let us focus
on the rst. The Feasibility Condition requires that we nd a set of labelings such that for every pair of
fragments, there is at least one labeling in which the pair is not mass degenerate. If there are p fragments,
the feasible labeling set L (when it exists), could be large, which would not be practical. Obviously, the
smaller p is, the better. This leads to the optimization version of our problem, which can be given as follows:
Labeling-Set Optimization: Minimize the size jLj of the Feasible Set of Labelings L.
3.2.2 Necessary vs. SuÆcient Conditions
We say that ambiguity occurs when, in a data spectrum, it is impossible to assign each mass peak to a unique
fragment, due to mass degeneracy. This makes it impossible to infer which fragment caused each peak, and
therefore we cannot infer which fragments are experimentally present.
Claim 2 The Feasibility Condition is worst-case necessary and suÆcient to eliminate ambiguity in the case
jLj = 1.
Claim 3 For jLj > 1, the Feasibility Condition is necessary but not suÆcient.
Proof: Necessity is denitional. We show it is not suÆcient. Suppose L = fX
1
; X
2
g. Let k; g
1
; g
2
be
fragments, and let  
i
(k) denote the mass of fragment k in labeling scheme X
i
. Suppose  
1
(k) =  
1
(g
1
),
 
1
(k) 6=  
1
(g
2
),  
2
(k) =  
2
(g
2
), and  
2
(k) 6=  
2
(g
1
). Then the Feasibility Condition holds, but it is
impossible to assign the k-g
1
or k-g
2
peaks. In particular, we cannot guarantee that k's presence or absence
can be inferred.
Claim 4 A SuÆcient Condition for jLj > 1 is given as follows: Find a set of labelings L such that for every
fragment k, there exists a labeling X
k
2 L such that, for every fragment g 6= k, f
kg
(X
k
) 6= 0.
In practice, the suÆcient condition in Claim 4 is much stronger than we need. One intuitive reason is
the potential for use of negative evidence: the absence of a peak in one labeled spectrum can disambiguate a
potential mass degeneracy in another. For example, in the proof of Claim 3, if fragment g
1
does not occur,
then the peak  
2
(g
1
) will be missing if  
 1
2
( 
2
(g
1
)) is a singleton. In this case, the k-g
1
peak in labeling X
1
can be unambiguously assigned to k. Thus, the suÆcient condition does not take into account the expected
information content of negative evidence. Note that this assumes that the quantity of a particular fragment is
dramatically reduced or completely absent. Since MS is not a quantitative method, a reduction in peak size
under some conditions could not be construed as negative evidence. The key point is that we do not require
that any peak must be absent: however, when a peak is experimentally absent, the algorithm can exploit
that information to make valid inferences about function. Since roughly s
4
  s fragments will not occur in
any experiment, we expect to nd a great deal of negative evidence. In the next section, we incorporate
negative evidence into the data analysis phase.
More intuition as to why the suÆcient condition might be stronger than needed follows from recognizing
that the necessary condition imposes O(s
8
) constraints on O(s
4
) fragment hypotheses. However, in any
physical experiment, only O(s) fragments will appear. These fragments are so constrained by the O(s
8
)
clauses of the necessary condition, that mass degeneracy under a feasible labeling is rare. The randomized
experiment planning algorithm described above can be viewed as \satiscing a necessary condition," as
opposed to optimally satisfying a necessary condition (which would mean minimizing jLj), or satisfying
a worst-case suÆcient condition like Claim 4 (which would be so pessimistic as to demand a very large
number of experiments). Our goal is to minimize or reduce the ambiguity from mass degeneracy in an
O(s)-size sample F

that is selected \randomly" from a larger, O(s
4
)-sized set F of fragment hypotheses,
given statistics on the mass degeneracy in F . In the probabilistic framework section below, we quantitate
these observations by modeling the statistical properties of mass degeneracy.
8
Let L = ;.
Let D = F F .
Repeat
Let X = a random labeling.
Set L L [ fXg.
Set D  f(k; l) 2 D j f
kl
(X) = 0g.
Until D = ;.
Table 1: Randomized experiment planning algorithm.
13
C-labeled
15
N-labeled P(interp)
Unlabeled Unlabeled 0.43
ARCEGILKSWV NDQEHILSWV 1.0
(a)
13
C-labeled
15
N-labeled  P(interp)
Unlabeled Unlabeled 27 0.021
NDQEHILKSTWV RCQHKMSTWYV 18 0.88
QGISWV ACQEGIKPY 10 0.99
ANDCEGHILS RCQGILMFPSWY 3 0.9998
ARNQEHKMSV ACQGLMWY 1 0.99999
DCQEILSW ANEGLKMFTWY 0 0.9999997
(b)
Table 2: Isotopically-labeled experiment planning results from the randomized algorithm. (a) Single exper-
iment disambiguating fragment masses for ubl1. (b) Sequence of experiments collectively disambiguating
fragment masses for ubc9.  = number of remaining ambiguities. P(interp) is the probability that spectral
dierencing can eliminate all incorrect fragments (Eq. (14)).
3.3 Experimental Results
It follows immediately from Lemma 1 that Labeling-Set Optimization is NP-hard. Therefore, we explored
how feasibility (without optimality) could be computed (i.e., to obtain a \small" number of unsatised con-
straints), with the randomized algorithm in Table 1. This algorithm merely checks the necessary condition.
Somewhat remarkably, in practice, this results in satisfying much stronger conditions (see below). One of our
goals is to elucidate why this is so. We believe that such an algorithm can yield eÆcient labeling strategies.
We applied the randomized algorithm to experiment planning for the proteins Ubiquitin Carrier Protein
(ubc9)
5
and Ubiquitin-Like Protein (ubl1)
6
under trypsin cleavage. The algorithm was run for 1000 trials,
with each trial identifying a set of experiments that disambiguate the fragments. A minimal-sized experiment
set (not necessarily unique) was chosen from this group. Two fragments were considered ambiguous if their
masses diered by less than one part per thousand. The computation required about three minutes of real
time on a 400MHz Pentium II machine, running interpreted Scheme code. Results, detailed in Table 2, show
that fragments of ubl1 can be disambiguated with one correctly-chosen isotopic labeling, and fragments of
ubc9 can be disambiguated with no more than ve labelings: the rst labeling leaves 18 ambiguous pairs, of
which only 10 are ambiguous with respect to the second labeling, and so forth. In a later section, we calculate
a probabilistic measure of how well these planned experiments are expected to eliminate mass degeneracy
(P(interp) in Table 2).
For the ubl1-ubc9 complex, the program identied 120 fragments for ubl1 and 276 fragments for ubc9,
5
ubc9 (or Human ubci), Accession # P50550/Q15698.
6
ubl1 (or Human sm33), Accession # P55856/Q93068.
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and thus 33516 fragments for the cross product. It then identied 434241 mass-degenerate pairs in this set
of fragments. This is far too many pairs for a small set of experiments to disambiguate, underscoring the
importance of computational modeling and prediction of feasible fragments in the complex. A reasonable
set of priors would restrict the number of functional hypotheses to a few hundred. Our experiments are
evidence that SAR by MS can discriminate among hundreds of hypotheses, which should be suÆcient for
many complexes of interest.
4 Data Analysis: Spectral Dierencing
Optimal experiment planning attempts to carefully design the experiments so that the data analysis devolves
to a table-lookup. The process is designed to minimize ambiguity in fragment hypothesis interpretation.
Without experiment planning to minimize mass degeneracy, the data analysis may yield ambiguous results
(i.e., competing fragment and binding-mode hypotheses). Since optimal experiment planning appears dif-
cult, in this section, we investigate an alternative approach, obtaining polynomial-time algorithms when
some potential ambiguity can be tolerated. A continuum of design tradeos is possible between planning
and analysis. To explore this idea, we picked a point near the other end of the design spectrum, in which
we assume that the experiment plan (labeling+cleavage) is given a priori, and the data analysis algorithm
reports on the hypotheses than can be inferred from the collected spectra. The hypotheses will typically
not be unique, since the experiment was not optimally planned. The next section presents a probabilistic
framework that uses the insights of this section to predict how well a non-optimal experiment plan will
actually perform.
Trained spectroscopists interpret mass spectra using a technique called spectral dierencing, in which
two spectra from dierent labelings of a complex (but using the same cleavage agents) are compared. For
example, a peak in an unlabeled (natural isotopic abundance) mass spectrum will shift to a higher mass
in a selectively
15
N-labeled spectrum (cf. Figs. 1 and 2). When peaks can be tracked across spectra, the
corresponding mass shifts can be used to infer which fragment generated the peak.
Given a complex and a xed cleavage agent, let S
i
be a mass spectrum, represented as a set of masses (at
observed peaks) fs
1
; s
2
; : : :g, under labeling scheme X
i
. X
i
= fx
1
; x
2
; : : :g is a vector of labels as in Eq. (5).
Let 
i
(s) be the set of fragments which could have produced peak s:

i
(s) = fk 2 F j s   
i
(k)g (7)
where  
i
(k) is the mass of fragment k under X
i
. Spectral dierencing then identies pairs of peaks in two
dierent spectra S
1
and S
2
such that the same fragment could have caused both peaks. We dene the set
of interpretations of the mass shift (s
1
; s
2
) for peaks s
1
2 S
1
and s
2
2 S
2
as I(s
1
; s
2
) = 
1
(s
1
)\ 
2
(s
2
). Due
to mass degeneracy, s
1
in spectrum S
1
could have multiple explaining fragments k 2 
1
(s). However, each
such k must also have a peak s
2
in spectrum S
2
with k 2 
2
(s
2
) in order to be consistent with the spectral
dierence. This approach uses negative evidence to rapidly prune the fragments being considered.
We now develop a fast algorithm for spectral dierencing. The dierence spectrum of S
1
and S
2
is
obtained from the Minkowski dierence S
2
	 S
1
= fs
2
  s
1
j s
2
2 S
2
; s
1
2 S
1
g as follows. In general, there
will be constraints on which pairs of peaks in S
1
 S
2
can participate in the dierence spectrum. In the
example above, X
1
= 0 (i.e., S
1
is unlabeled) and X
2
contains only positive and zero increments. This means
that all mass shifts must be between 0 and some maximum value t that depends on the primary sequence
(for example, if all Arginine residues are labeled with
15
N, then the upper bound t for the mass shift of a
fragment is given by the maximum number of Arg residues in any fragment times n^
2
= 4). There will be a
lower bound l as well (for example, l = 0 if there is any Arginine-free fragment), and in general l and t can
be made tighter by varying as functions of s
1
. Hence, we dene the dierence spectrum as
D(S
1
; S
2
) = f(s
1
; s
2
) 2 S
1
 S
2
j s
2
  s
1
2 [l(s
1
); t(s
1
)]g: (8)
Now, suppose a peak s 2 S
1
is caused by a fragment f
k
. Following Eq. (5), we obtain
s = N(f
k
)  (M +X
1
): (9)
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Hence, N(f
k
) is simply the vector encoding the counts of each residue type. Now, because of mass degeneracy,
we may also have other fragments f
2
, f
3
, etc. that can cause s. That is, s = N(f
2
)  (M + X
1
), s =
N(f
3
)  (M +X
1
), as well. Suppose (s; r) 2 D(S
1
; S
2
), i.e., r is a candidate match for s across spectra. We
say a fragment f
k
explains the mass shift (s; r) when Eq. (9) holds and
r   s = N(f
k
)  (X
2
 X
1
): (10)
Thus the set of interpretations of the mass shift (s; r) can be rewritten
I(s; r) = ff
k
2 F j Eqs. (9) and (10) holdg: (11)
Finally, given two spectra S
1
and S
2
with labelings X
1
and X
2
, the set I(D(S
1
; S
2
)) represents the fragment
hypotheses consistent with the dierence spectrum.
We now develop an output-sensitive algorithm for computing the consistent fragment hypotheses I(D(S
1
; S
2
)).
Consider a dimeric protein complex P with n residues. Given a cleavage agent , we obtain a crosslinked
and cleaved system P(), containing both 1- and 2-fragments. While the set of possible fragments that could
make up P() is large (O(n
4
)), in any particular P() we will see only O(n) 1-fragments (see the section on
basic combinatorics). A priori, there could be O(n
2
) 2-fragments, but we do not expect it is geometrically
feasible for every pair of 1-fragments to crosslink. Therefore, we expect to observe only O(n) 2-fragments.
Hence, we expect the size c of the crosslinked and cleaved system P() to be O(n).
For larger proteins, we nd that in practice, the mass values are only accurate to some uncertainty
bound ". To cope with this uncertainty, we employ 1D range-searching:
Claim 5 Suppose we are given two spectra S
1
and S
2
of a crosslinked and cleaved system P() with labelings
X
1
and X
2
(respectively), together with a tolerance " representing the resolution of the spectra. Then the
fragment hypotheses consistent with the toleranced dierence spectrum can be computed in output-sensitive
time O(c
2
logn) where c is the size of P(), using O(n
4
logn) preprocessing time.
Proof: To compute I(D(S
1
; S
2
)), we create a binary range tree [9] storing for each fragment f the interval
[z(f)   "; z(f) + "] and the datum f , where z(f) = N(f)  (X
2
  X
1
). This preprocessing requires time
O(n
4
logn). Given a potential mass shift, we perform a tree lookup in time O(logn). The size of the
dierence spectrum is bounded above by the size of the Minkowski sum S
2
	 S
1
, which is O(c
2
). Thus, we
do O(c
2
) lookups in time O(c
2
logn). For each non-empty lookup, we also check in O(1) time that Eq. (9)
holds.
Corollary 6 Spectral dierencing under uncertainty can be extended to analyze spectra from d selective
labeling schemes, with O(dc
2
logn) running time and O(dn
4
logn) preprocessing time.
Although the O(n
4
logn) preprocessing time is nontrivial, we envision it could be done in parallel with
the wetlab molecular biology (selective labeling), which can take on the order of days. After preprocessing,
the O(c
2
logn) computational lookup phase should be very fast, on a similar timescale to MS recording.
Spectral dierencing can also be used to compare spectra from single proteins against spectra for a
complex of the proteins (see Ex. 3). While we omit detailed discussion, the algorithm is similar to that
above.
5 Probabilistic Mass Degeneracy
The data analysis techniques discussed in the previous section correlate information among multiple spec-
tra from dierent labelings, overcoming mass degeneracy by eliminating fragment hypotheses that are not
consistent with all spectra. Since there are a large number of fragment hypotheses (O(s
4
)) but only a small
number of observed peaks (O(s)), it is likely that many potential ambiguities can be resolved by spectral
dierencing, given experimental data. The experiment planning suÆcient condition (Claim 4) operates with-
out experimental data, assuming the worst case, and thus may be far too strict in practice. This section
derives probabilistic measures that approximate the likelihood that spectral dierencing will be able to re-
solve potential ambiguities. In particular, we distinguish correct and incorrect fragment hypotheses as those
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that respectively do and do not correspond to peptides existing in the sample. We then address the fol-
lowing question: How likely is it that some incorrect fragment hypotheses cannot be eliminated due to mass
degeneracy with correct fragment hypotheses?
Claim 7 Spectral dierencing fails to eliminate all incorrect fragment hypotheses if and only if there exists
an incorrect fragment hypothesis k, such that, for each labeling X 2 L, there exists a correct fragment
hypothesis l
X
such that f
kl
X
(X) = 0.
The negation of the condition in Claim 7 indicates when spectral dierencing can eliminate all incorrect
fragment hypotheses. Note that this does not mean that all peaks will be uniquely assigned, since the
correct fragment hypotheses might be mass degenerate. However, it does mean that exactly the correct
hypotheses will be identied, which is our objective. This novel approach of identifying correct answers
without relying on assignment has also proved useful in NMR data analysis [7].
5.1 Probabilistic Framework
To compute the likelihood of satisfying Claim 7 with a given set of labelings L, rst impose a distribution on
the a priori probability that a fragment is correct. For simplicity, we assume here that this is uniform: the
expected number of correct hypotheses p

= E(jF

j) divided by the number of possible hypotheses p = jFj.
An upper bound can be derived by setting the expected number of correct hypotheses p

to the number
of fragments in the completely-digested protein. Any available modeling assumptions can be incorporated
into this distribution. In the derivation below, let } = 1   p

=p denote the fraction of incorrect fragment
hypotheses, and let  
i
(f) denote the mass of fragment f in labeling i. The derivation assumes the mass
degeneracies in the dierent labelings are independent; if that is not the case, a longer but qualitatively
similar formula results.
We say a particular incorrect fragment hypothesis f appears in a particular experiment i unless all of the
fragment hypotheses with which it would be mass degenerate are also incorrect. Let C(f; i) =  
 1
i
( 
i
(f))
denote the conict set (mass-degenerate fragments) of fragment f in experiment i and c(f; i) = jC(f; i)j be
the size of the conict set. Then
P (appears(f; i)) = 1 
Y
g2C(f;i)
P (incorrect(g))
= 1  }
c(f;i)
: (12)
We say a particular incorrect fragment hypothesis f is eliminatable unless for all experiments i 2 L, f
appears in i.
P (elim(f; L)) = 1 
Y
i2L
P (appears(f; i))
= 1 
Y
i2L
(1  }
c(f;i)
): (13)
An incorrect fragment hypothesis f is uneliminatable when it is not eliminatable.
Finally, a set of labelings L is interpretable (Claim 7 is unsatised) if for all fragments f , f is not both
incorrect and uneliminatable.
P (interpretable(L))
=
Y
f2F
(1  P (incorrect(f))  (1  P (elim(f; L))))
=
Y
f2F
(1  } 
Y
i2L
(1  }
c(f;i)
)): (14)
Eq. (14) denes an interpretability metric for a set of labelings, indicating how likely it is that spectral
dierencing will be able to eliminate all incorrect fragment hypotheses.
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Figure 3: Interpretability of randomly planned sets of 1, 2, and 5 labelings (left to right), for (a) ubl1 and
(b) ubc9. Each bar indicates how many sets, out of 100, have the given probability of interpretability.
5.2 Experimental Results
We have tested the interpretability metric for the proteins previously discussed. Refer back to Table 2: the
last column gives the interpretability metric for both the unlabeled protein and the labeled protein. Note
that the metric converges to 1.0 with the addition of more labelings distinguishing more mass-degenerate
pairs, demonstrating the power of spectral dierencing to combine information across experiments. In the
extreme case, when the suÆcient condition (Claim 4) is satised (as with the planned labeling for ubl1),
the metric equals 1.0.
We have also studied the ability of random labeling sets to satisfy the interpretability condition. Fig. 3
shows histograms of the metric for sets of 1, 2, and 5 random labeling sets, with 100 samples generating each
histogram. As these plots illustrate, the interpretability metric provides a concrete indication that ubl1
is easier to disambiguate than ubc9. Randomization is able to eectively sample the space of labelings,
and our planning algorithm can nd sets of labelings that, with high probability, spectral dierencing will
be able to interpret. Fig. 3 shows empirical evidence that the Randomized Algorithm (Table 1) and the
interpretability metric (Eq. (14)) are mutually benecial, and may be combined in a package for experiment
planning to probabilistically eliminate mass degeneracy.
6 Conclusion
MALDI MS is a fast experimental technique requiring subpicomolar sample sizes. It is therefore attractive
for high-throughput functional genomics studies. However, the information extracted is rather minimalist
compared to NMR or Xray crystallography, so a large burden is placed on the algorithmic problems of exper-
iment planning and data analysis. In this paper, we explored the problem of eliminating mass degeneracy in
SAR by MS, developing an experiment planning framework that seeks to maximize the information content
of an SAR by MS experiment, and an eÆcient data analysis algorithm that interprets the resulting data. We
investigated optimal experiment planning (omsep) where the objective is to minimize mass degeneracy, and
showed that, under fairly natural conditions, a
13
C-only variant of this problem is NP-complete. We then
explored more tractable subclasses, tradeos, and implementation experiments. We developed a randomized
algorithm that processes across spectra to eliminate mass degeneracy. While this technique appears to be
eÆcient, it does not minimize the number of experiments. We implemented and tested the algorithm in a
study of the protein-protein complex Ubiquitin Carrier Protein/Ubiquitin-Like Protein (SMT3C).
On the other hand, if we are given an a priori experiment plan, we can use the information content in
the dierence spectra to track mass shifts. This more sophisticated data analysis can be done eÆciently, and
13
we provide an output-sensitive, polynomial time algorithm for the spectral-dierencing data analysis. Using
spectral dierencing, we then derived probabilistic bounds on actual mass degeneracy using an analysis of
the statistics of hypothesis degeneracy. This let us quantitate the eectiveness of the randomized algorithm.
Computational experiments on the SMT3C system support our construction of a data-driven necessary and
suÆcient condition (Eq. (14)) for probabilistic mass degeneracy.
The algorithms and bounds we explored represent rst steps in a computational framework for SAR by
MS. We believe this will be a dynamic and fruitful area for future research.
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Appendix
A Lower Bounds (Proof of Lemma 1)
We wish to show that omsep is a diÆcult problem, by showing that it is NP-complete. There are several
diÆculties in proving a real biological or biochemical problem to be NP-hard. First, the number of amino
acids is xed at 20 and the maximum \reasonable" size of a protein is also xed by nature, so in a complexity-
theoretic sense all problems can be solved in constant time. Of course this doesn't capture the observed
complexity of these problems. Thus, we will allow the number of amino acids and the length of the protein
to be variables. In the case of protein size, this is a standard abstraction that has been used elsewhere. It is
less standard for the number of amino acid types, but we believe the combinatorial argument in the problem
denition section justies this abstraction.
There is another way in which an NP-completeness proof may fail to capture true biochemical problems.
A biochemical problem may have restrictions on the possible input parameters that don't arise in other types
of problems. For example, to show that a problem with a non-negative input parameter x is NP-hard, it is
suÆcient to show that it is NP-hard when x is restricted to be 0 or 1. However, this might not be suÆcient
for a biochemical problem in which x is a physical parameter, such as mass, and restricting it to be 0 or 1
leaves a set of problems that are not physically realizable or interesting. Thus the challenge, roughly, is to
show that set of instances which are hard has a non-empty intersection with the set of problems that arise
biochemically.
The following problem BIN FLS 6=, (Feasible Linear System with f0; 1g variables and 6= constraints), is
known to be NP-complete [1, 2]:
Problem name: BIN FLS 6=
Input: a
ij
2 Q ; i = 1; : : : ; n; j = 1; : : : ;m and b
i
2 Q ; i = 1; : : : n.
Problem denition: Does there exist x
j
2 f0; 1g; j = 1; : : : ;m such that
m
X
j=1
a
ij
x
j
6= b
i
; i = 1; : : : ; n (15)
See [3, 17, 5, 4, 6, 18] for other related work on BIN FLS.
Lemma 8 For every instance of BIN FLS 6=, and any set of r
i
, with the size of each r
i
bounded by a
polynomial in the original input size, i = 1; : : : n, there is an equivalent instance with n +m variables and
2n inequalities, in which n of the right hand sides are r
i
, i = 1; : : : n, and n are 0.
Proof: Let the n additional binary variables be called y
1
; : : : ; y
n
. Then we form the following system of 2n
inequalities. Consider the following modied problem:
m
X
j=1
a
ij
x
j
+ (r
i
  b
i
)y
i
6= r
i
; i = 1; : : : ; n (16)
y
i
6= 0; i = 1; : : : ; n (17)
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Since in any satisfying assignment, all the y
i
's must be 1, this instance is algebraically equivalent to the BIN
FLS 6= one.
Lemma 8 tells us we have the freedom to choose any rational right hand sides; in particular we can choose
them as functions of biochemical parameters and still have an NP-complete problem.
We now introduce an variant of omsep, in which only
13
C selective labeling is permitted. We call this
problem
13
C-omsep-sat:
Problem name:
13
C-omsep-sat
Input: m amino acids z
1
; : : : ; z
m
, each with c
j
carbons and mass m
j
(c
j
> 0 and m
j
> 0 for proteins).
n constraints, where a constraint i can be specied by m coeÆcients h
ij
where (h
i1
; h
i2
; : : : ; h
im
) is the
\dierence vector" N
kl
in Eq. (3) (h
ij
the j
th
element of the vector N
kl
, corresponding to the dierence in
the number of residues of amino acid type j).
Problem denition: Each of the n constraints can be written as
m
X
j=1
h
ij
(c
j
x
j
+m
j
) 6= 0 (18)
where x
j
2 f0; 1g. Can we simultaneously satisfy all the constraints?
Claim 9
13
C-omsep-sat is NP-hard.
Proof. The proof is by reduction from BIN FLS 6=. Assume WLOG that a
ij
2 Z (i = 1; : : : n; j = 1; : : :m)
(if not, multiply both sides of Eq. (15) by 1=q where q is the LCM of the denominators of the a
ij
). By
Lemma 8, we know we can create an instance in which we specify the right hand sides. We will set
b
i
=  
m
X
j=1
a
ij
m
j
c
j
: (19)
Given such an instance of BIN FLS 6=, we create an instance of
13
C-omsep-sat. Note that all m
j
and c
j
,
j = 1; : : :m, are chosen by nature. For each j = 1; : : :m; i = 1; : : : n, we set
h
ij
= a
ij
Y
k 6=j
c
k
: (20)
Now let's look at our system of inequalities:
m
X
j=1
h
ij
(c
j
x
j
+m
j
) 6= 0 i = 1; : : : ; n: (21)
Making the substitutions from the mapping, we get, for i = 1; : : : ; n:
m
X
j=1
a
ij
0
@
Y
k 6=j
c
k
1
A
(c
j
x
j
) +
m
X
j=1
a
ij
0
@
Y
k 6=j
c
k
1
A
m
j
6= 0 (22)
or
m
X
j=1
a
ij
0
@
Y
k 6=j
c
k
1
A
(c
j
x
j
) 6=  
m
X
j=1
a
ij
0
@
Y
k 6=j
c
k
1
A
m
j
: (23)
But
m
X
j=1
a
ij
0
@
Y
k 6=j
c
k
1
A
(c
j
x
j
) =
m
X
j=1
a
ij
 
Y
k
c
k
!
x
j
=
 
Y
k
c
k
!
m
X
j=1
a
ij
x
j
; (24)
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so we can rewrite the inequalities as
 
Y
k
c
k
!
m
X
j=1
a
ij
x
j
6=  
 
Y
k
c
k
!
m
X
j=1
a
ij
m
j
c
j
(25)
so this system is just the system (15) scaled by (
Q
k
c
k
), and so is satisable if and only if (15) is. Note
that we can add a set of dummy variables and set them to one to obtain the exact form of Lemma 8. If any
rational coeÆcient r
i
  b
i
is non-integral, we can clear denominators by multiplying by one over the LCM
as described above.
If we let the largest number in the input be D, then the input to BIN FLS 6= is of size O(nm logD). In
our problem, the largest number can be as large as n!D, which means that the input is of size O(nm(n logn+
logD), which is just a polynomial blowup.
Problem name:
13
C-omsep
Input: Identical to
13
C-omsep-sat. The constraints are again given in the form of Eq. (18).
Problem denition: Can we nd a set of assignments x
j
2 f0; 1g, (j = 1; : : : ;m) that minimizes the number
of unsatised constraints?
Lemma 1
13
C-omsep is NP-complete.
Proof: NP-hardness follows directly from Claim 9.
13
C-omsep is in NP because it is an instance of the
NP-problem Minimum Unsatisfying Linear Subsystem (muls) [3, 17, 5, 4, 6, 18, 1].
We have thus shown that the problem of determining whether a set of mass degeneracy constraints
is simultaneously satisable is NP-hard. Recall that each constraint is generated by a pair of fragment
hypotheses, and each fragment participates in many constraints. It is therefore natural to ask whether there
exists a real protein that could actually generate exactly the constraints that arise in our reductions. If we
take the view that all pairs of fragments potentially interact, and we don't know a priori which ones will
interact, then we cannot answer this question. If, on the other hand, as discussed in the introduction, we
use a priori binding-mode and -region hypotheses to limit the constraints that the planner must address,
the situation is dierent. Then we can construct a protein for a set of constraints by generating, for each
constraint i = 1; : : : ; n, a pair of fragments with the appropriate mass dierence given by the dierence vector
N
kl
in Eq. (3), namely (h
i1
; h
i2
; : : : ; h
im
). We then focus experiment planning on only the designated pairs
by using an input set of a priori hypotheses eliminating from consideration other pairwise fragment-fragment
constraints.
It is worth asking whether such a reduction is biologically relevant. It may be unlikely that such a protein
will be expressed naturally in the proteome of an organism. However, making such a protein is certainly
within the capability of standard biotechnology (where, given any de novo, designed primary sequence, the
techniques of standard recombinant DNA, protein overexpression, and purication can be used to produce
a sample). Until a distribution of \hard" vs. \easy" naturally occurring proteins can be obtained, we feel
the result of Lemma 1, which is realizable biotechnologically, provides insight into the empirically observed
combinatorial diÆculty of the problem.
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